跳至主要内容
临床试验/IRCT2013112515536N1
IRCT2013112515536N1已完成未知

Effect of supplementation of quercetin on inflammatory factor and adiponectin andgene expression of its receptors in women’s PBMC with polycystic ovarysyndrome(PCOS)

Tehran University of Medical Sciences0 个研究点目标入组 42 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 40 years(—)
性别
Female

入选标准

  • BMI 25 to 40 - the age range of 20-40 years - according to the Rotterdam conference, at least two of the three criteria listed as having the disease. Features include menstrual irregularities, or clinical symptoms and the presence of polycystic ovaries on ultrasound – Hyperandrogenism.
  • donot use drugs; contraceptive drugs, antihypertensive drugs lower blood lipid and anti-inflammatory drug- and willing to cooperate.
  • Exclusion criteria: Endocrine and metabolic diseases such as hypothyroidism and hyperthyroidism, androgen producing cancer, diabetes mellitus, adrenal hyperplasia and Cushing, ovarian tumor and Hyperprolactinaemia - Smoking - Pregnancy - allergic reaction to supplements - Cancel patient to cooperate in the study.

排除标准

  • 未提供

研究者

相似试验